Home Blog of Signal Transduction DNA Damage/DNA Repair Topoisomerase Probing the interactions of mitoxantrone with biomimetic membranes with electrochemical and spectroscopic techniques

Category

Archives

Popular Post

ESKM, a novel therapeutic agent for sensitive and resistant PH+ leukemias

The mechanism of resistance to JAK2 inhibitor in myeloproliferative neoplasms patients

Effects of PARP inhibitors in BRCA gene-mutated ovarian cancer

DASATINIB; An inhibitor of Receptor Tyrosine Kinase

GP130/JAK/STAT3 signaling pathway induces multiple myeloma

Probing the interactions of mitoxantrone with biomimetic membranes with electrochemical and spectroscopic techniques

Mitoxantrone – an anticancer drug – was used to probe the interactions of this class of cytostatic molecules with biomimetic monolayers. The drug effect was monitored with electrochemical (cyclic voltammetry and electrochemical impedance spectroscopy), as well as spectroscopic techniques (surface enhanced Raman scattering), during its passive partitioning/penetration through the mixed Langmuir and Langmuir–Blodgett monolayers after their transfer on gold electrodes. This approach allowed us to discriminate between the drug interactions with hydrophilic head-group region and hydrophobic alkyl chains moiety of such monolayers.

Related Products

Cat.No. Product Name Information
S2485 Mitoxantrone 2HCl Mitoxantrone 2HCl is a dihydrochloride salt of Mitoxantrone. Mitoxantrone is an inhibitor of type II topoisomerase and protein kinase C (PKC) with IC50 of 8.5 μM for PKC. Mitoxantrone inhibits cell proliferative growth of MCF-7/wt cells with IC50 of 0.42 μM. Mitoxantrone also induces apoptosis.

Related Targets

Topoisomerase